VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+5.45%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$243M
AUM Growth
+$243M
(+2.7%)
Cap. Flow
-$3.35M
Cap. Flow
% of AUM
-1.38%
Top 10 Holdings %
Top 10 Hldgs %
7.68%
Holding
410
New
55
Increased
156
Reduced
186
Closed
11
Top Buys
| 1 |
BKCC
BlackRock Capital Investment Corporation
BKCC
|
$670K |
| 2 |
Zai Lab
ZLAB
|
$520K |
| 3 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$422K |
| 4 |
DRD
DRDGold
DRD
|
$405K |
| 5 |
Stellus Capital Investment Corp
SCM
|
$402K |
Top Sells
| 1 |
AMRS
Amyris Inc.
AMRS
|
$1.28M |
| 2 |
Prothena Corp
PRTA
|
$971K |
| 3 |
BioNTech
BNTX
|
$787K |
| 4 |
RUBY
Rubius Therapeutics, Inc
RUBY
|
$647K |
| 5 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$645K |
Sector Composition
| 1 | Healthcare | 27.38% |
| 2 | Real Estate | 18.81% |
| 3 | Energy | 13.29% |
| 4 | Materials | 10.7% |
| 5 | Utilities | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Barings BDC
BBDC
$987M
| $715K | 0.29% |
67,728
+6,969
| +11% | +$73.6K |
|
102
TriplePoint Venture Growth BDC
TPVG
$273M
| $699K | 0.29% |
46,048
+13,884
| +43% | +$211K |
|
103
New Mountain Finance
NMFC
$1.12B
| $695K | 0.29% |
52,779
+12,267
| +30% | +$162K |
|
|
BGB
104
Blackstone Strategic Credit 2027 Term Fund
BGB
$557M
| $693K | 0.29% |
49,719
+13,467
| +37% | +$188K |
|
105
WhiteHorse Finance
WHF
$199M
| $692K | 0.28% |
46,474
+11,699
| +34% | +$174K |
|
106
Goldman Sachs BDC
GSBD
$1.3B
| $661K | 0.27% |
33,704
+7,819
| +30% | +$153K |
|
|
107
Stellus Capital Investment Corp
SCM
$414M
| $660K | 0.27% |
52,459
+31,990
| +156% | +$402K |
|
108
PennantPark Floating Rate Capital
PFLT
$1.01B
| $654K | 0.27% |
51,448
+13,397
| +35% | +$170K |
|
|
KIO
109
KKR Income Opportunities Fund
KIO
$512M
| $650K | 0.27% |
38,973
+9,591
| +33% | +$160K |
|
110
BlackRock TCP Capital
TCPC
$606M
| $624K | 0.26% |
45,117
+3,281
| +8% | +$45.4K |
|
111
Capital Southwest
CSWC
$1.27B
| $623K | 0.26% |
26,814
+4,001
| +18% | +$93K |
|
112
SLR Investment Corp
SLRC
$903M
| $619K | 0.25% |
33,226
+12,316
| +59% | +$229K |
|
113
Prospect Capital
PSEC
$1.34B
| $612K | 0.25% |
72,943
+12,370
| +20% | +$104K |
|
114
Fidus Investment
FDUS
$756M
| $611K | 0.25% |
35,966
+434
| +1% | +$7.37K |
|
115
Ares Capital
ARCC
$15.7B
| $599K | 0.25% |
30,592
+7,725
| +34% | +$151K |
|
116
Ironwood Pharmaceuticals
IRWD
$201M
| $572K | 0.24% |
44,421
-6,890
| -13% | -$88.7K |
|
117
Golub Capital BDC
GBDC
$3.91B
| $567K | 0.23% |
36,791
+8,943
| +32% | +$138K |
|
118
Hercules Capital
HTGC
$3.51B
| $567K | 0.23% |
33,252
+7,373
| +28% | +$126K |
|
119
Horizon Technology Finance
HRZN
$296M
| $566K | 0.23% |
32,800
+5,110
| +18% | +$88.2K |
|
120
Moderna
MRNA
$9.36B
| $566K | 0.23% |
2,407
-1,624
| -40% | -$382K |
|
121
Gladstone Capital
GLAD
$581M
| $560K | 0.23% |
49,001
+8,635
| +21% | +$98.7K |
|
122
Vanda Pharmaceuticals
VNDA
$279M
| $556K | 0.23% |
25,870
-22,044
| -46% | -$474K |
|
123
Saratoga Investment
SAR
$401M
| $555K | 0.23% |
20,643
+4,105
| +25% | +$110K |
|
|
FCT
124
First Trust Senior Floating Rate Income Fund II
FCT
$263M
| $548K | 0.23% |
43,175
+12,853
| +42% | +$163K |
|
|
BSL
125
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$186M
| $546K | 0.22% |
33,386
+5,848
| +21% | +$95.6K |
|